Rallis India Limited · NSE:RALLIS
Rallis India — Q1 FY22 Earnings Presentation
17 slides from Rallis India's earnings presentation, Jul 22, 2021
Slide 1: Submission of Analysts/Investors Presentation to stock exchanges
July 21, 2021 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza Dalal Street Bandra-Kurla Complex Bandra (E) Mumbai – 400 001 Mumbai – 400 051 Scrip Code: 500355 Symbol: RALLIS Dear Sir/Madam, Sub: Submission of Analysts/Investors Presentation Ref: Letter
Slide 2: Results Presentation Q1 FY22
Results Presentation Q1 FY22 1
Slide 3: Disclaimer
Disclaimer This presentation, except for the historical information, may contain statements, including the words or phrases such as ‘expects, anticipates, intends, will, would, undertakes, aims, estimates, contemplates, seeks to, objective, goal, projects, should’ and similar expressions or variatio
Slide 4: Rallis – Businesses
Rallis – Businesses Well entrenched connect with the Indian farmer Chemistry ● Crop Protection ● Partnering with global innovators (International ● Plant growth (Domestic business) ● Strong R&D and business) ● Nutrients(PGN) executional capabilities ● Soil conditioner ● Environmentally ● Seeds adher
Slide 5: Domestic business
Domestic business Leading Agrochemical Company Presence across value chain: Seeds – Soil Conditioners – Crop Protection Chemicals - Plant Growth Nutrients Market share: ~ 6% (Crop protection & PGN), ~3% (Seeds) Strong & Healthy pipeline of sustainable products Nationwide footprint – Crop Care: 3700+
Slide 6: International Business
International Business Manufacturing Technicals for global Agro chemicals players Key products – Pendimethalin: Used as a pre-emergence herbicide to control annual grasses and certain broad leaved weeds. Global a.i market size: 394 Mn USD (Calendar Year 2019) – Acephate: An organophosphate foliar an
Slide 7: Seed business
Seed business Rallis develops, produces and sells hybrid seeds including Paddy, Millet, Maize and Bt Cotton; Kharif season accounts for 80-85% revenues Strong market position - among top 3 in Hybrid Paddy (3rd) & Hybrid Millet (2nd) and Maize (6th). With around a million packets sold, our Bt Cotton
Slide 8: Business Strategy
Business Strategy Long Term Domestic Business: Research led new a.is Medium Term and combination formulations to build a Domestic Business: Widening portfolio with value strong and innovative product portfolio added innovative formulations and build Short Term International Business: Widening partne
Slide 9: Growth Drivers
Growth Drivers o Focus on innovation - New Formulations, New a.is In-house, Partnerships , Domestic Nutrients Business o Strengthen and leverage brand power o Augment distribution reach o Capacity expansion of existing molecules and resume few discontinued products International o Expand B2B base an
Slide 10: Q1 FY22 - Performance Highlights: Overall
Q1 FY22 - Performance Highlights: Overall Rs Crs ● 11.7% growth YoY. Crop Care grew ● PAT drop coming from EBITDA ● Margins have been impacted by by 17.4% and Seeds by 3.1% shortfall. pricing pressure, limiting our ability ● 31% revenue growth on YoY basis in to fully pass on the steep cost ● Lower
Slide 11: Q1 FY22 - Performance Highlights: Crop Care division
Q1 FY22 - Performance Highlights: Crop Care division Rs Cr ● Crop care revenues grew by 17.4% YoY ● Margins have been impacted by pricing ● PAT drop coming from EBITDA pressure, limiting our ability to fully shortfall. ● 31% revenue growth on YoY basis in pass on the steep cost inflation. the domest
Slide 12: Q1 FY22 - Performance Highlights: Seeds Division
Q1 FY22 - Performance Highlights : Seeds Division Rs Cr ● 3.1% growth in topline in Q1 FY22 supported by volume Growth in Paddy ● Margins are at almost similar level to ● PAT is at almost similar level to PY PY . ● Growth impacted due to influx of illegal HT cotton. 11 Copyright © Rallis India Limit
Slide 13: Category-wise Revenue Split Q1 FY22
Category-wise Revenue Split Q1 FY22 Note: revenue breakup is for Crop Protection; Crop Care consist of crop protection, crop nutrition, Polymer and others 12 Copyright © Rallis India Limited. All rights reserved.
Slide 14: Revenue Split Domestic/International Q1 FY22
Revenue Split Domestic/International Q1 FY22 Note: Revenue breakup is for Crop Care Lower share due to international business spillover impact of sales in base quarter. 13 Copyright © Rallis India Limited. All rights reserved.
Slide 15: Capex - Update
Capex - Update • Overall Capex implementation impacted due to COVID 19 Wave II : delayed by 2- 3 months • Ankleshwar debottlenecking project for two a.i’s completing in Q2 FY22 • MPP project progressing well • Formulation Plant at Dahej, CZ - Phase 1 Expected now to be completed by Q2 FY22 • Metri g
Slide 16: Operational Highlights
Operational Highlights New Product Progress – ❖ DF - Launched new 9(3) formulation in Q1 – Pepe (Pendimethalin + Penoxsulam) targeted as a herbicide in Rice; 9(4) formulation Preet Plus (Pretilachlor) targeted as a Rice herbicide and Kaushal (Propineb) targeted as a fungicide in F&V segment ❖ PGN -
Slide 17: THANK YOU
THANK YOU Copyright © Rallis India Limited. All rights reserved. 16 1 6